Institute of Neurology, Campus Biomedico University, Rome, Italy; Fondazione Alberto Sordi - Research Institute for Ageing, Rome, Italy.
Neurosci Lett. 2013 Oct 11;553:148-52. doi: 10.1016/j.neulet.2013.08.013. Epub 2013 Aug 23.
Non-invasive brain stimulation is presently being tested as a potential therapeutic intervention for stroke rehabilitation. Following a model of competitive interactions between the hemispheres, these interventions aim to increase the plasticity of stroke hemisphere by applying either excitatory protocols to the damaged hemisphere or inhibitory protocols to the non-stroke hemisphere. Here we test the safety and feasibility of using an inhibitory protocol on the stroke hemisphere to improve the response to conventional therapy via a homeostatic increase in learning capacity. Twelve chronic stroke patients received TBS to stroke hemisphere (6 patients inhibitory TBS and 6 sham TBS) followed by physical therapy daily for 10 working days. Patients and therapists were blinded to the type of TBS. Action Research Arm Test (ARAT), Nine-Hole Pegboard Test (NHPT) and Jebsen-Taylor Test (JTT) were the primary outcome measures, grip and pinch-grip dynamometry were the secondary outcome measures. All patients improved ARAT and JTT scores for up to 3 months post-treatment. ARAT scores improved significantly in both real and sham groups, but only patients receiving real TBS significantly improved on the JTT: 3 months post-treatment mean execution time was reduced compared to baseline by 141 s for real group and by 65s for the sham group. This small exploratory study suggests that ipsilesional inhibitory TBS is safe and that it has the potential to be used in a larger trial to enhance the gain from a late rehabilitation program in chronic stroke patients.
非侵入性脑刺激目前正在被测试作为中风康复的一种潜在治疗干预手段。这些干预措施遵循半球之间竞争相互作用的模型,旨在通过对受损半球应用兴奋性方案或对非中风半球应用抑制性方案来增加中风半球的可塑性。在这里,我们通过增加学习能力的稳态来测试对中风半球应用抑制性方案以改善对常规治疗的反应的安全性和可行性。12 名慢性中风患者接受 TBS 治疗中风半球(6 名患者接受抑制性 TBS,6 名患者接受假 TBS),随后每天进行 10 个工作日的物理治疗。患者和治疗师对 TBS 的类型不知情。动作研究臂测试(ARAT)、九孔钉板测试(NHPT)和杰普森-泰勒测试(JTT)是主要的结果测量指标,握力和捏力测力计是次要的结果测量指标。所有患者在治疗后长达 3 个月的时间内 ARAT 和 JTT 评分均有所提高。真实组和假组的 ARAT 评分均显著提高,但仅接受真实 TBS 的患者在 JTT 上的改善显著:与基线相比,治疗后 3 个月的执行时间分别减少了 141 秒和 65 秒。这项小型探索性研究表明,同侧抑制性 TBS 是安全的,并且有可能在更大的试验中使用,以增强慢性中风患者晚期康复计划的收益。